ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,390,500, issued on Aug. 19, was assigned to Sichuan Real & Best Biotech Co. Ltd. (Sichuan, China).

"Pharmaceutical composition of a recombinant adeno-associated virus vector and its application" was invented by Yi Zeng (Sichuan, China) and Jialing Jiang (Sichuan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention belongs to the field of formulation of a recombinant adeno-associated virus vector, in particular relating to a pharmaceutical composition of a recombinant adeno-associated virus vector, comprising a recombinant adeno-associated virus (rAAV), an ion salt, a buffering agent, a stabilizer, and a surfactant, and its use. Th...